Comparative Haematology International

, Volume 2, Issue 1, pp 24–26 | Cite as

An in vitro comparison of the oxidative effects of two structurally related cephalosporins on normal canine and human haemolysate

  • J. Batchelor
  • J. Fuller
  • D. D. Woodman
Original Article


Two structurally related cephalosporins which produced haemolytic anaemia in the dog were compared in an in vitro test system which demonstrated oxidative changes in haemolysates prepared from canine and human erythrocytes. This system utilised lead acetate as an inhibitor of the antioxidant enzymes of the pentose phosphate pathway.

Increased methaemoglobin production was induced in haemolysates by both compounds but whereas lead acetate exacerbated the oxidant effect of one, a dihydroxy phenol cephalosporin, it did not exacerbate this effect of the other (cefoperazone), whose structure included a monohydroxy phenol side chain.

Under the in vitro conditions of the investigation, it was also evident that canine haemolysate showed much greater susceptibility to oxidation than human haemolysate.


Cephalosporins Haemolytic anaemia Lead acetate Methaemoglobin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Beutler E, Dern RJ, Alving AS (1954) The hemolytic effect of primaquine: IV. The relationship of cell age to hemolysis. J Lab Clin Med 44:439–442PubMedGoogle Scholar
  2. Beutler E, Dern RJ, Flanagan CL, Alving AS (1955) The hemolytic effect of primaquine: VII. Biochemical studies of drug sensitive erythrocytes. J Lab Clin Med 45:286–295PubMedGoogle Scholar
  3. Carson PE, Flanagan CL, Ickes CE Alving AS (1956) Enzymatic deficiency in primaquine-sensitive erythrocytes. Science 124:484PubMedCrossRefGoogle Scholar
  4. Imai K, Matsura M, Furukawa H, Hayashi Y (1975) [Oxidant-drug induced hemolytic anemia in dogs]. Folia Pharmacol Jpn 71:691–707 (Engl Abstr)CrossRefGoogle Scholar
  5. Jandl JH, Files NM, Barnett SB, Macdonald RA (1965) Proliferative response of the spleen and liver to hemolysis. J Exp Med 122:299–326PubMedCrossRefGoogle Scholar
  6. Lachant NA, Tomoda A, Tanaka KR (1984) Inhibition of the pentose phosphate shunt by lead: a potential mechanism for hemolysis in lead poisoning. Blood 63:518–524PubMedGoogle Scholar
  7. Lawson NW, Schnitzer B, Smith EB (1969) Splenic ultrastructure in drug-induced Heinz body hemolysis. Arch Pathol 87:491–501PubMedGoogle Scholar
  8. Scott AI (1967) Proceedings of the European Society for the study of Drug Toxicity 9:185Google Scholar
  9. Tarlov AR, Kellermeyer RW (1961) The hemolytic effect of primaquine. XI. Decreased catalase activity in primaquine sensitive cells. J Lab Clin Med 58:204PubMedGoogle Scholar
  10. Yoneda T, Masatani H, Shibata T et al. (1980) Subacute toxicity test of cefoperazone in beagle dogs with the intravenous administration for three months (authors translation). Jpn J Antibiot 33:1028–1055 (Engl Abstr)PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • J. Batchelor
    • 1
  • J. Fuller
    • 1
  • D. D. Woodman
    • 1
  1. 1.Chemical Pathology UnitSmithKline Beecham PharmaceuticalsThe Frythe, WelwynUK

Personalised recommendations